Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
While there is an increasing interest in the correlation of cystic fibrosis transmembrane conductance regulator (CFTR) and cancer incidence, the role of CFTR in nasopharyngeal carcinoma (NPC) development remains unknown.
|
27769067 |
2016 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
While there is an increasing interest in the correlation of cystic fibrosis transmembrane conductance regulator (CFTR) and cancer incidence, the role of CFTR in nasopharyngeal carcinoma (NPC) development remains unknown.
|
27769067 |
2016 |
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
BEFREE |
While the safety and effectiveness remain to be demonstrated, these observations suggest the feasibility of in vivo CFTR gene transfer as therapy for the pulmonary manifestations of CF.
|
1370653 |
1992 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
While over 1000 mutations in CFTR have been associated with CF, the majority of cases are linked to the deletion of phenylalanine 508 (delta F508).
|
18080175 |
2007 |
Lung diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
While all patients with cystic fibrosis (CF) have mutations in both CFTR alleles, often only one CFTR change is detected in patients with other lung disorders.
|
15151509 |
2004 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
While all patients with cystic fibrosis (CF) have mutations in both CFTR alleles, often only one CFTR change is detected in patients with other lung disorders.
|
15151509 |
2004 |
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
BEFREE |
While a major target in cystic fibrosis (CF) research in recent years has been the development of corrector and potentiator drugs targeting the cystic fibrosis transmembrane conductance regulator (CFTR) protein, these therapies have not yet proven robust enough to replace or eliminate other therapies that have demonstrated improved health outcomes and quality of life in patients with CF.
|
26335956 |
2015 |
Pancreatitis, Chronic
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
While CFTR modulation has been shown to alkalinize the pH of the alimentary tract and potentially augment pancreatic enzyme activity, the effect of ivacaftor on recurrent pancreatitis is emerging.
|
31296159 |
2019 |
Recurrent pancreatitis
|
0.160 |
AlteredExpression
|
disease |
BEFREE |
While CFTR modulation has been shown to alkalinize the pH of the alimentary tract and potentially augment pancreatic enzyme activity, the effect of ivacaftor on recurrent pancreatitis is emerging.
|
31296159 |
2019 |
Lung diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
While CFTR-directed therapy has the highest potential to improve patients' outcome, it is important to continue to develop better treatment options for all aspects of CF lung disease.
|
24479826 |
2014 |
Respiratory Failure
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Whereas some complex-glycosylated CFTR was often present in rectal biopsies of F508del homozygous subjects, no mature CFTR was detectable in CF lungs at the stage of terminal respiratory insufficiency.
|
22832190 |
2012 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Whereas some complex-glycosylated CFTR was often present in rectal biopsies of F508del homozygous subjects, no mature CFTR was detectable in CF lungs at the stage of terminal respiratory insufficiency.
|
22832190 |
2012 |
Cystic Fibrosis
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Whereas mutant CFTR expression in leukocytes outside of the lung does not markedly impair their function, the expected regulation of inflammation in the airways is clearly deficient in cystic fibrosis.
|
22481418 |
2012 |
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
BEFREE |
Where evidence is available for the impact of CFTR modulatory therapy, namely ivacaftor on comorbidities in CF, this is highlighted.
|
28554721 |
2017 |
Cystic Fibrosis
|
1.000 |
Biomarker
|
disease |
LHGDN |
When we restored the F508del-CFTR trafficking in CFTR-reverted cells, the specific IP3R activity was also reduced to a similar level as in non CF cells.
|
18973672 |
2008 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
When these findings are taken together, it may be seen that mature CFTR inhibits <i>C. jejuni</i> invasion by regulating microtubule-mediated pathways.
|
28784926 |
2017 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
When the histological features of the breast cancers with a deltaF508 CFTR mutation were reviewed and graded using a combined architectural and cytological grading system, all were found to be grade III, poorly differentiated tumours, contrary to the predictions.
|
9761117 |
1998 |
Malignant neoplasm of breast
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
When the histological features of the breast cancers with a deltaF508 CFTR mutation were reviewed and graded using a combined architectural and cytological grading system, all were found to be grade III, poorly differentiated tumours, contrary to the predictions.
|
9761117 |
1998 |
Cystic Fibrosis
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
When normal CFTR cDNA was overexpressed via a retroviral vector in CF or normal airway epithelial cells or in mouse fibroblasts, the protein produced had an apparent molecular mass of about 180 kDa.
|
1370488 |
1992 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
When miR mimics are expressed in CF lung or pancreatic cells, the expression of the F508del-CFTR protein is significantly increased.
|
26133785 |
2015 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype.
|
14685937 |
2004 |
Cystic Fibrosis
|
1.000 |
CausalMutation
|
disease |
CLINVAR |
When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype.
|
14685937 |
2004 |
Cystic Fibrosis
|
1.000 |
GeneticVariation
|
disease |
CLINVAR |
When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype.
|
14685937 |
2004 |
Cholangitis, Sclerosing
|
0.040 |
GeneticVariation
|
disease |
LHGDN |
What is the role of cystic fibrosis transmembrane conductance regulator dysfunction in primary sclerosing cholangitis?
|
17719926 |
2007 |
VAS DEFERENS, CONGENITAL BILATERAL ABSENCE OF
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
What can the CF registry tell us about rare CFTR-mutations? A Belgian study.
|
28830496 |
2017 |